A Phase 3, Open-Label, Randomized Study of Perioperative Dostarlimab Monotherapy Versus Standard of Care in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

Principal Investigator: Siru Mäkelä
Trial site: HUS Comprehensive Cancer Center

Link to the ClinicalTrials.gov website